Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
Total Valuation
Clinigence Holdings has a market cap or net worth of $776.80M. The enterprise value is $528.08M.
Market Cap$776.80M
Enterprise Value$528.08M
Share Statistics
Clinigence Holdings has 5,528,448 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,528,448
Owned by Insiders35.02%
Owned by Institutions1.25%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.02%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.02%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee599.94K
Profits Per Employee119.09K
Employee Count800
Asset Turnover<0.01
Inventory Turnover0.10
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 3.10. Clinigence Holdings’s PEG ratio is -0.02.
PE Ratio3.10
PS Ratio1.08
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF<0.01
Price to Operating Cash Flow<0.01
PEG Ratio-0.02
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 479.95M and earned 52.18M in profits. Earnings per share was 10.23.
Revenue479.95M
Gross Profit196.26M
Operating Income130.62M
Pretax Income109.75M
Net Income52.18M
EBITDA148.65M
Earnings Per Share (EPS)10.23
Cash Flow
In the last 12 months, operating cash flow was 23.15B and capital expenditures 0.00, giving a free cash flow of 23.15B billion.
Operating Cash Flow23.15B
Free Cash Flow23.15B
Free Cash Flow per Share4.19K
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.26
52-Week Price Change1766.16%
50-Day Moving Average75.80
200-Day Moving Average38.49
Relative Strength Index (RSI)61.23
Average Volume (3m)104.72K
Important Dates
Clinigence Holdings upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Clinigence Holdings as a current ratio of 2.08, with Debt / Equity ratio of 155.67%
Current Ratio2.08
Quick Ratio2.06
Debt to Market Cap1.94K
Net Debt to EBITDA1.82K
Interest Coverage Ratio6.55
Taxes
In the past 12 months, Clinigence Holdings has paid 14.48M in taxes.
Income Tax14.48M
Effective Tax Rate0.13
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 1.82K, with an EV/FCF ratio of 11.70.
EV to Sales564.35
EV to EBITDA1.82K
EV to Free Cash Flow11.70
EV to Operating Cash Flow11.70
Balance Sheet
Clinigence Holdings has $43.58B in cash and marketable securities with $314.28B in debt, giving a net cash position of $270.70B billion.
Cash & Marketable Securities$43.58B
Total Debt$314.28B
Net Cash$270.70B
Net Cash Per Share$48.96K
Tangible Book Value Per Share$33.81K
Margins
Gross margin is 40.89%, with operating margin of 27.22%, and net profit margin of 10.87%.
Gross Margin40.89%
Operating Margin27.22%
Pretax Margin22.87%
Net Profit Margin10.87%
EBITDA Margin30.97%
EBIT Margin27.02%
Analyst Forecast
The average price target for Clinigence Holdings is $125.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$125.00
Price Target Upside-11.04% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast93.80%
EPS Growth Forecast―